Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 11/2012

01-11-2012 | Article

Cytokine genetic profile in Whipple’s disease

Authors: F. Biagi, C. Badulli, G. E. Feurle, C. Müller, V. Moos, T. Schneider, T. Marth, J. Mytilineos, F. Garlaschelli, A. Marchese, L. Trotta, P. I. Bianchi, M. Di Stefano, A. L. Cremaschi, A. De Silvestri, L. Salvaneschi, M. Martinetti, G. R. Corazza

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 11/2012

Login to get access

Abstract

Whipple’s disease (WD) is a very rare chronic systemic condition characterised by a Th2/T regulatory (Treg) dysregulated immune response versus Tropheryma whipplei, a bacterium widely diffuse in the environment. To investigate whether this Th2/Treg polarised response has a genetic background, we investigated the Th1, Th2, Th17 and Treg cytokine genetic profile of 133 patients with WD. Thanks to the European Consortium on WD (QLG1-CT-2002-01049), the polymorphism of 13 cytokine genes was analysed in 111 German and 22 Italian patients using the polymerase chain reaction with sequence-specific primers (PCR-SSP) technique. The frequencies of the genotypes, haplotypes and functional phenotypes were compared with those obtained in 201 German and 140 Italian controls. Clinical heterogeneity was also considered. Functionally, WD patients may be considered as low producers of TGF-β1, having an increased frequency of the genotype TGF-β1+869C/C,+915C/C [12.3 % vs. 3.81 %, odds ratio (OR) = 4.131, p = 0.0002] and high secretors of IL-4, carrying the genotype IL-4-590T/T (5.34 % vs. 1.17 %, OR = 5.09, p = 0.0096). No significant association was found between cytokine polymorphism and clinical variability. Analogously to the recent cellular findings of a Th2/Treg polarised response, we showed that the cytokine genetic profile of WD patients is skewed toward a Th2 and Treg response. This was similar in both German and Italian populations. However, the significant deviations versus the controls are poorer than that expected on the basis of these recent cellular findings.
Literature
2.
go back to reference Moos V, Schneider T (2011) Changing paradigms in Whipple’s disease and infection with Tropheryma whipplei. Eur J Clin Microbiol Infect Dis 30:1151–1158PubMedCrossRef Moos V, Schneider T (2011) Changing paradigms in Whipple’s disease and infection with Tropheryma whipplei. Eur J Clin Microbiol Infect Dis 30:1151–1158PubMedCrossRef
3.
go back to reference Maiwald M, Schuhmacher F, Ditton H-J, von Herbay A (1998) Environmental occurrence of the Whipple’s disease bacterium (Tropheryma whippelii). Appl Environ Microbiol 64:760–762PubMed Maiwald M, Schuhmacher F, Ditton H-J, von Herbay A (1998) Environmental occurrence of the Whipple’s disease bacterium (Tropheryma whippelii). Appl Environ Microbiol 64:760–762PubMed
4.
go back to reference Zinkernagel AS, Gmür R, Fenner L, Schaffner A, Schoedon G, Schneemann M (2003) Marginal and subgingival plaque—a natural habitat of Tropheryma whipplei? Infection 31:86–91PubMedCrossRef Zinkernagel AS, Gmür R, Fenner L, Schaffner A, Schoedon G, Schneemann M (2003) Marginal and subgingival plaque—a natural habitat of Tropheryma whipplei? Infection 31:86–91PubMedCrossRef
5.
go back to reference Schöniger-Hekele M, Petermann D, Weber B, Müller C (2007) Tropheryma whipplei in the environment: survey of sewage plant influxes and sewage plant workers. Appl Environ Microbiol 73:2033–2035PubMedCrossRef Schöniger-Hekele M, Petermann D, Weber B, Müller C (2007) Tropheryma whipplei in the environment: survey of sewage plant influxes and sewage plant workers. Appl Environ Microbiol 73:2033–2035PubMedCrossRef
6.
go back to reference Fenollar F, Trani M, Davoust B, Salle B, Birg ML, Rolain JM, Raoult D (2008) Prevalence of asymptomatic Tropheryma whipplei carriage among humans and nonhuman primates. J Infect Dis 197:880–887PubMedCrossRef Fenollar F, Trani M, Davoust B, Salle B, Birg ML, Rolain JM, Raoult D (2008) Prevalence of asymptomatic Tropheryma whipplei carriage among humans and nonhuman primates. J Infect Dis 197:880–887PubMedCrossRef
7.
go back to reference Li W, Fenollar F, Rolain J-M, Fournier P-E, Feurle GE, Müller C, Moos V, Marth T, Altwegg M, Calligaris-Maibach RC, Schneider T, Biagi F, La Scola B, Raoult D (2008) Genotyping reveals a wide heterogeneity of Tropheryma whipplei. Microbiology 154:521–527PubMedCrossRef Li W, Fenollar F, Rolain J-M, Fournier P-E, Feurle GE, Müller C, Moos V, Marth T, Altwegg M, Calligaris-Maibach RC, Schneider T, Biagi F, La Scola B, Raoult D (2008) Genotyping reveals a wide heterogeneity of Tropheryma whipplei. Microbiology 154:521–527PubMedCrossRef
8.
go back to reference Fenollar F, Mediannikov O, Socolovschi C, Bassene H, Diatta G, Richet H, Tall A, Sokhna C, Trape JF, Raoult D (2010) Tropheryma whipplei bacteremia during fever in rural West Africa. Clin Infect Dis 51:515–521PubMedCrossRef Fenollar F, Mediannikov O, Socolovschi C, Bassene H, Diatta G, Richet H, Tall A, Sokhna C, Trape JF, Raoult D (2010) Tropheryma whipplei bacteremia during fever in rural West Africa. Clin Infect Dis 51:515–521PubMedCrossRef
9.
go back to reference Raoult D, Fenollar F, Rolain JM, Minodier P, Bosdure E, Li W, Garnier JM, Richet H (2010) Tropheryma whipplei in children with gastroenteritis. Emerg Infect Dis 16:776–782PubMedCrossRef Raoult D, Fenollar F, Rolain JM, Minodier P, Bosdure E, Li W, Garnier JM, Richet H (2010) Tropheryma whipplei in children with gastroenteritis. Emerg Infect Dis 16:776–782PubMedCrossRef
10.
go back to reference Martinetti M, Biagi F, Badulli C, Feurle GE, Müller C, Moos V, Schneider T, Marth T, Marchese A, Trotta L, Sachetto S, Pasi A, De Silvestri A, Salvaneschi L, Corazza GR (2009) The HLA alleles DRB1*13 and DQB1*06 are associated to Whipple’s disease. Gastroenterology 136:2289–2294PubMedCrossRef Martinetti M, Biagi F, Badulli C, Feurle GE, Müller C, Moos V, Schneider T, Marth T, Marchese A, Trotta L, Sachetto S, Pasi A, De Silvestri A, Salvaneschi L, Corazza GR (2009) The HLA alleles DRB1*13 and DQB1*06 are associated to Whipple’s disease. Gastroenterology 136:2289–2294PubMedCrossRef
11.
go back to reference Ponz de Leon M, Borghi A, Ferrara F, Contri M, Roncucci L (2006) Whipple’s disease in a father–son pair. Intern Emerg Med 1:254–256PubMedCrossRef Ponz de Leon M, Borghi A, Ferrara F, Contri M, Roncucci L (2006) Whipple’s disease in a father–son pair. Intern Emerg Med 1:254–256PubMedCrossRef
12.
go back to reference Dykman DD, Cuccherini BA, Fuss IJ, Blum LW, Woodward JE, Strober W (1999) Whipple’s disease in a father–daughter pair. Dig Dis Sci 44:2542–2544PubMedCrossRef Dykman DD, Cuccherini BA, Fuss IJ, Blum LW, Woodward JE, Strober W (1999) Whipple’s disease in a father–daughter pair. Dig Dis Sci 44:2542–2544PubMedCrossRef
13.
go back to reference Gross JB, Wollaeger EE, Sauer WG, Huizenga KA, Dahlin DC, Power MH (1959) Whipple’s disease; report of four cases, including two in brothers, with observations on pathologic physiology, diagnosis, and treatment. Gastroenterology 36:65–93PubMed Gross JB, Wollaeger EE, Sauer WG, Huizenga KA, Dahlin DC, Power MH (1959) Whipple’s disease; report of four cases, including two in brothers, with observations on pathologic physiology, diagnosis, and treatment. Gastroenterology 36:65–93PubMed
14.
go back to reference Desnues B, Ihrig M, Raoult D, Mege JL (2006) Whipple’s disease: a macrophage disease. Clin Vaccine Immunol 13:170–178PubMedCrossRef Desnues B, Ihrig M, Raoult D, Mege JL (2006) Whipple’s disease: a macrophage disease. Clin Vaccine Immunol 13:170–178PubMedCrossRef
15.
go back to reference Moos V, Schmidt C, Geelhaar A, Kunkel D, Allers K, Schinnerling K, Loddenkemper C, Fenollar F, Moter A, Raoult D, Ignatius R, Schneider T (2010) Impaired immune functions of monocytes and macrophages in Whipple’s disease. Gastroenterology 138:210–220PubMedCrossRef Moos V, Schmidt C, Geelhaar A, Kunkel D, Allers K, Schinnerling K, Loddenkemper C, Fenollar F, Moter A, Raoult D, Ignatius R, Schneider T (2010) Impaired immune functions of monocytes and macrophages in Whipple’s disease. Gastroenterology 138:210–220PubMedCrossRef
16.
go back to reference Benoit M, Desnues B, Mege JL (2008) Macrophage polarization in bacterial infections. J Immunol 181:3733–3739PubMed Benoit M, Desnues B, Mege JL (2008) Macrophage polarization in bacterial infections. J Immunol 181:3733–3739PubMed
17.
go back to reference Desnues B, Lepidi H, Raoult D, Mege JL (2005) Whipple disease: intestinal infiltrating cells exhibit a transcriptional pattern of M2/alternatively activated macrophages. J Infect Dis 192:1642–1646PubMedCrossRef Desnues B, Lepidi H, Raoult D, Mege JL (2005) Whipple disease: intestinal infiltrating cells exhibit a transcriptional pattern of M2/alternatively activated macrophages. J Infect Dis 192:1642–1646PubMedCrossRef
18.
go back to reference Marth T, Neurath M, Cuccherini BA, Strober W (1997) Defects of monocyte interleukin 12 production and humoral immunity in Whipple’s disease. Gastroenterology 113:442–448PubMedCrossRef Marth T, Neurath M, Cuccherini BA, Strober W (1997) Defects of monocyte interleukin 12 production and humoral immunity in Whipple’s disease. Gastroenterology 113:442–448PubMedCrossRef
19.
go back to reference Marth T, Kleen N, Stallmach A, Ring S, Aziz S, Schmidt C, Strober W, Zeitz M, Schneider T (2002) Dysregulated peripheral and mucosal Th1/Th2 response in Whipple’s disease. Gastroenterology 123:1468–1477PubMedCrossRef Marth T, Kleen N, Stallmach A, Ring S, Aziz S, Schmidt C, Strober W, Zeitz M, Schneider T (2002) Dysregulated peripheral and mucosal Th1/Th2 response in Whipple’s disease. Gastroenterology 123:1468–1477PubMedCrossRef
20.
go back to reference Moos V, Kunkel D, Marth T, Feurle GE, LaScola B, Ignatius R, Zeitz M, Schneider T (2006) Reduced peripheral and mucosal Tropheryma whipplei-specific Th1 response in patients with Whipple’s disease. J Immunol 177:2015–2022PubMed Moos V, Kunkel D, Marth T, Feurle GE, LaScola B, Ignatius R, Zeitz M, Schneider T (2006) Reduced peripheral and mucosal Tropheryma whipplei-specific Th1 response in patients with Whipple’s disease. J Immunol 177:2015–2022PubMed
21.
go back to reference Schinnerling K, Moos V, Geelhaar A, Allers K, Loddenkemper C, Friebel J, Conrad K, Kühl AA, Erben U, Schneider T (2011) Regulatory T cells in patients with Whipple’s disease. J Immunol 187:4061–4067PubMedCrossRef Schinnerling K, Moos V, Geelhaar A, Allers K, Loddenkemper C, Friebel J, Conrad K, Kühl AA, Erben U, Schneider T (2011) Regulatory T cells in patients with Whipple’s disease. J Immunol 187:4061–4067PubMedCrossRef
22.
go back to reference Blaschitz C, Raffatellu M (2010) Th17 cytokines and the gut mucosal barrier. J Clin Immunol 30:196–203PubMedCrossRef Blaschitz C, Raffatellu M (2010) Th17 cytokines and the gut mucosal barrier. J Clin Immunol 30:196–203PubMedCrossRef
23.
go back to reference Peck A, Mellins ED (2010) Plasticity of T-cell phenotype and function: the T helper type 17 example. Immunology 129:147–153PubMedCrossRef Peck A, Mellins ED (2010) Plasticity of T-cell phenotype and function: the T helper type 17 example. Immunology 129:147–153PubMedCrossRef
24.
go back to reference Savage ND, de Boer T, Walburg KV, Joosten SA, van Meijgaarden K, Geluk A, Ottenhoff TH (2008) Human anti-inflammatory macrophages induce Foxp3+ GITR+ CD25+ regulatory T cells, which suppress via membrane-bound TGFβ-1. J Immunol 181:2220–2226PubMed Savage ND, de Boer T, Walburg KV, Joosten SA, van Meijgaarden K, Geluk A, Ottenhoff TH (2008) Human anti-inflammatory macrophages induce Foxp3+ GITR+ CD25+ regulatory T cells, which suppress via membrane-bound TGFβ-1. J Immunol 181:2220–2226PubMed
26.
go back to reference Feurle GE, Moos V, Schinnerling K, Geelhaar A, Allers K, Biagi F, Bläker H, Moter A, Loddenkemper C, Jansen A, Schneider T (2010) The immune reconstitution inflammatory syndrome in Whipple disease: a cohort study. Ann Intern Med 153:710–717PubMed Feurle GE, Moos V, Schinnerling K, Geelhaar A, Allers K, Biagi F, Bläker H, Moter A, Loddenkemper C, Jansen A, Schneider T (2010) The immune reconstitution inflammatory syndrome in Whipple disease: a cohort study. Ann Intern Med 153:710–717PubMed
27.
go back to reference Uboldi de Capei MU, Dametto E, Fasano ME, Rendine S, Curtoni ES (2003) Genotyping for cytokine polymorphisms: allele frequencies in the Italian population. Eur J Immunogenet 30:5–10PubMedCrossRef Uboldi de Capei MU, Dametto E, Fasano ME, Rendine S, Curtoni ES (2003) Genotyping for cytokine polymorphisms: allele frequencies in the Italian population. Eur J Immunogenet 30:5–10PubMedCrossRef
28.
go back to reference Gao L, Weck MN, Nieters A, Brenner H (2009) Association between a pro-inflammatory genetic profile and the risk of chronic atrophic gastritis among older adults from Germany. Eur J Cancer 45:428–434PubMedCrossRef Gao L, Weck MN, Nieters A, Brenner H (2009) Association between a pro-inflammatory genetic profile and the risk of chronic atrophic gastritis among older adults from Germany. Eur J Cancer 45:428–434PubMedCrossRef
29.
go back to reference Deriban G, Marth T (2006) Current concepts of immunopathogenesis, diagnosis and therapy in Whipple’s disease. Curr Med Chem 13:2921–2926PubMedCrossRef Deriban G, Marth T (2006) Current concepts of immunopathogenesis, diagnosis and therapy in Whipple’s disease. Curr Med Chem 13:2921–2926PubMedCrossRef
30.
go back to reference Mantel PY, Schmidt-Weber CB (2011) Transforming growth factor-beta: recent advances on its role in immune tolerance. Methods Mol Biol 677:303–338PubMedCrossRef Mantel PY, Schmidt-Weber CB (2011) Transforming growth factor-beta: recent advances on its role in immune tolerance. Methods Mol Biol 677:303–338PubMedCrossRef
Metadata
Title
Cytokine genetic profile in Whipple’s disease
Authors
F. Biagi
C. Badulli
G. E. Feurle
C. Müller
V. Moos
T. Schneider
T. Marth
J. Mytilineos
F. Garlaschelli
A. Marchese
L. Trotta
P. I. Bianchi
M. Di Stefano
A. L. Cremaschi
A. De Silvestri
L. Salvaneschi
M. Martinetti
G. R. Corazza
Publication date
01-11-2012
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 11/2012
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-012-1677-8

Other articles of this Issue 11/2012

European Journal of Clinical Microbiology & Infectious Diseases 11/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine